X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1

Miyake, Noriko, Wolf, Nicole I., Cayami, Ferdy K., Crawford, Joanna, Bley, Annette, Bulas, Dorothy, Conant, Alex, Bent, Stephen J., Gripp, Karen W., Hahn, Andreas, Humphray, Sean, Kimura-Ohba, Shihoko, Kingsbury, Zoya, Lajoie, Bryan R., Lal, Dennis, Micha, Dimitra, Pizzino, Amy, Sinke, Richard J., Sival, Deborah, Stolte-Dijkstra, Irene, Superti-Furga, Andrea, Ulrick, Nicole, Taft, Ryan J., Ogata, Tsutomu, Ozono, Keiichi, Matsumoto, Naomichi, Neubauer, Bernd A., Simons, Cas and Vanderver, Adeline (2017) X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1. Neurogenetics, 18 4: 1-10. doi:10.1007/s10048-017-0520-x


Author Miyake, Noriko
Wolf, Nicole I.
Cayami, Ferdy K.
Crawford, Joanna
Bley, Annette
Bulas, Dorothy
Conant, Alex
Bent, Stephen J.
Gripp, Karen W.
Hahn, Andreas
Humphray, Sean
Kimura-Ohba, Shihoko
Kingsbury, Zoya
Lajoie, Bryan R.
Lal, Dennis
Micha, Dimitra
Pizzino, Amy
Sinke, Richard J.
Sival, Deborah
Stolte-Dijkstra, Irene
Superti-Furga, Andrea
Ulrick, Nicole
Taft, Ryan J.
Ogata, Tsutomu
Ozono, Keiichi
Matsumoto, Naomichi
Neubauer, Bernd A.
Simons, Cas
Vanderver, Adeline
Title X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1
Journal name Neurogenetics   Check publisher's open access policy
ISSN 1364-6753
1364-6745
Publication date 2017-08-26
Year available 2017
Sub-type Article (original research)
DOI 10.1007/s10048-017-0520-x
Open Access Status Not yet assessed
Volume 18
Issue 4
Start page 1
End page 10
Total pages 10
Place of publication NEW YORK
Publisher Springer Verlag
Language eng
Subject 1311 Genetics
2716 Genetics (clinical)
2804 Cellular and Molecular Neuroscience
Abstract An X-linked condition characterized by the combination of hypomyelinating leukodystrophy and spondylometaphyseal dysplasia (H-SMD) has been observed in only four families, with linkage to Xq25-27, and recent genetic characterization in two families with a common AIFM1 mutation. In our study, 12 patients (6 families) with H-SMD were identified and underwent comprehensive assessment accompanied by whole-exome sequencing (WES). Pedigree analysis in all families was consistent with X-linked recessive inheritance. Presentation typically occurred between 12 and 36 months. In addition to the two disease-defining features of spondylometaphyseal dysplasia and hypomyelination on MRI, common clinical signs and symptoms included motor deterioration, spasticity, tremor, ataxia, dysarthria, cognitive defects, pulmonary hypertension, nystagmus, and vision loss due to retinopathy. The course of the disease was slowly progressive. All patients had maternally inherited or de novo mutations in or near exon 7 of AIFM1, within a region of 70 bp, including synonymous and intronic changes. AIFM1 mutations have previously been associated with neurologic presentations as varied as intellectual disability, hearing loss, neuropathy, and striatal necrosis, while AIFM1 mutations in this small region present with a distinct phenotype implicating bone. Analysis of cell lines derived from four patients identified significant reductions in AIFM1 mRNA and protein levels in osteoblasts. We hypothesize that AIFM1 functions in bone metabolism and myelination and is responsible for the unique phenotype in this condition.
Keyword AIFM1 gene
Hypomyelination
Mitochondrial leukodystrophy
Myelin
Spondylometaphyseal dysplasia
Whole exome sequencing (WES)
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: Scopus Import
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Thu, 23 Nov 2017, 23:51:44 EST